Anti-IOD2/ DIO2/ 5DII monoclonal antibody

Anti-IOD2/ DIO2/ 5DII antibody for FACS & in-vivo assay

Target products collectionGo to DIO2/DIO2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP0359-Ab-1/ GM-Tg-hg-MP0359-Ab-2Anti-Human DIO2 monoclonal antibodyHuman
GM-Tg-rg-MP0359-Ab-1/ GM-Tg-rg-MP0359-Ab-2Anti-Rat DIO2 monoclonal antibodyRat
GM-Tg-mg-MP0359-Ab-1/ GM-Tg-mg-MP0359-Ab-2Anti-Mouse DIO2 monoclonal antibodyMouse
GM-Tg-cynog-MP0359-Ab-1/ GM-Tg-cynog-MP0359-Ab-2Anti-Cynomolgus/ Rhesus macaque DIO2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP0359-Ab-1/ GM-Tg-felg-MP0359-Ab-2Anti-Feline DIO2 monoclonal antibodyFeline
GM-Tg-cang-MP0359-Ab-1/ GM-Tg-cang-MP0359-Ab-2Anti-Canine DIO2 monoclonal antibodyCanine
GM-Tg-bovg-MP0359-Ab-1/ GM-Tg-bovg-MP0359-Ab-2Anti-Bovine DIO2 monoclonal antibodyBovine
GM-Tg-equg-MP0359-Ab-1/ GM-Tg-equg-MP0359-Ab-2Anti-Equine DIO2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP0359-Ab-1/ GM-Tg-hg-MP0359-Ab-2; GM-Tg-rg-MP0359-Ab-1/ GM-Tg-rg-MP0359-Ab-2;
GM-Tg-mg-MP0359-Ab-1/ GM-Tg-mg-MP0359-Ab-2; GM-Tg-cynog-MP0359-Ab-1/ GM-Tg-cynog-MP0359-Ab-2;
GM-Tg-felg-MP0359-Ab-1/ GM-Tg-felg-MP0359-Ab-2; GM-Tg-cang-MP0359-Ab-1/ GM-Tg-cang-MP0359-Ab-2;
GM-Tg-bovg-MP0359-Ab-1/ GM-Tg-bovg-MP0359-Ab-2; GM-Tg-equg-MP0359-Ab-1/ GM-Tg-equg-MP0359-Ab-2
Products NameAnti-DIO2 monoclonal antibody
Formatmab
Target NameDIO2
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-DIO2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species IOD2/ DIO2/ 5DII VLP (virus-like particle) (Products Developing)
    ORF Viral VectorvGMAD000267human DIO2 Adenovirus particle
    ORF Viral VectorpGMAD000267human DIO2 Adenovirus plasmid
    ORF Viral VectorpGMLPm001586mouse Dio2 Lentivirus plasmid
    ORF Viral VectorvGMLPm001586mouse Dio2 Lentivirus particle


    Target information

    Target IDGM-MP0359
    Target NameDIO2
    Gene ID1734,13371,65162,707484,490813,101088170,494548,100052547
    Gene Symbol and Synonyms5DII,D2,DIO2,DIOII,SELENOY,SelY,TXDI2
    Uniprot AccessionQ92813,P70551,Q5I3B2
    Uniprot Entry NameIOD2_HUMAN,IOD2_RAT,IOD2_BOVIN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000211448
    Target ClassificationN/A

    The target: DIO2, gene name: DIO2, also named as 5DII, D2, DIOII, SelY, TXDI2. The protein encoded by this gene belongs to the iodothyronine deiodinase family. It catalyzes the conversion of prohormone thyroxine (3,5,3',5'-tetraiodothyronine, T4) to the bioactive thyroid hormone (3,5,3'-triiodothyronine, T3) by outer ring 5'-deiodination. This gene is widely expressed, including in thyroid and brain. It is thought to be responsible for the 'local' production of T3, and thus important in influencing thyroid hormone action in these tissues. It has also been reported to be highly expressed in thyroids of patients with Graves disease, and in follicular adenomas. The intrathyroidal T4 to T3 conversion by this enzyme may contribute significantly to the relative increase in thyroidal T3 production in these patients. This protein is a selenoprotein containing the non-standard amino acid, selenocysteine (Sec), which is encoded by the UGA codon that normally signals translation termination. The 3' UTRs of selenoprotein mRNAs contain a conserved stem-loop structure, designated the Sec insertion sequence (SECIS) element, that is necessary for the recognition of UGA as a Sec codon, rather than as a stop signal. Unlike the other two members (DIO1 and DIO3) of this enzyme family, the mRNA for this gene contains an additional in-frame UGA codon that has been reported (in human) to function either as a Sec or a stop codon, which can result in two isoforms with one or two Sec residues; however, only the upstream Sec (conserved with the single Sec residue found at the active site in DIO1 and DIO3) was shown to be essential for enzyme activity (PMID:10403186). Alternatively spliced transcript variants have been described for this gene. [provided by RefSeq, Oct 2018].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.